Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, TuHURA Biosciences's Enterprise Value is $0.00 Mil.
TuHURA Biosciences does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2022. Therefore, GuruFocus does not calculate TuHURA Biosciences's EV-to-EBIT at this moment.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, TuHURA Biosciences's Enterprise Value is $0.00 Mil.
TuHURA Biosciences does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2022. Therefore, GuruFocus does not calculate TuHURA Biosciences's EV-to-EBITDA at this moment.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, TuHURA Biosciences's Enterprise Value is $0.00 Mil.
TuHURA Biosciences does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Dec. 2022. Therefore, GuruFocus does not calculate TuHURA Biosciences's EV-to-Revenue at this moment.
TuHURA Biosciences Enterprise Value Historical Data
The historical data trend for TuHURA Biosciences's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
TuHURA Biosciences Enterprise Value Chart
TuHURA Biosciences Annual Data
Trend
Dec21
Dec22
Enterprise Value
-
-
TuHURA Biosciences Semi-Annual Data
Dec21
Dec22
Enterprise Value
-
-
Competitive Comparison of TuHURA Biosciences's Enterprise Value
For the Biotechnology subindustry, TuHURA Biosciences's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TuHURA Biosciences's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's Enterprise Value distribution charts can be found below:
* The bar in red indicates where TuHURA Biosciences's Enterprise Value falls into.
TuHURA Biosciences Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
TuHURA Biosciences's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TuHURA Biosciences (NAS:HURA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
TuHURA Biosciences Enterprise Value Related Terms
Thank you for viewing the detailed overview of TuHURA Biosciences's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
TuHURA Biosciences (TuHURA Biosciences) Business Description
10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
Website
TuHURA Biosciences Inc is a clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to current immunotherapies. The company's lead personalized cancer vaccine candidate, IFx-Hu2.0, is designed to prime the activation of the immune system to target and attack tumor cells by making them look like bacteria. Through an intratumoral injection of a gene coding for emm55, an immunogenic bacterial protein that is then expressed on the surface of tumor cells, the immune system is activated, providing a potent, multivalent systemic response against all neoantigens in a patient's tumor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HURA has been successfully added to your